Notably, a 2022 study revealed that ELOVL2 is significantly upregulated in PCa compared to normal prostate tissue and regulates cancer cell behavior through INPP4B signaling, further underscoring its importance in PCa progression (Hu et al., 2022). This evidence concerns the gene ELOVL2 and cancer.